Literature DB >> 20589648

Continuously improving ifosfamide/mesna: a winning combination.

Peter Anderson1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20589648     DOI： 10.1002/pbc.22652

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN： 1545-5009            Impact factor:   3.167


× No keyword cloud information.
  7 in total

Review 1.  Radiopharmaceuticals for Treatment of Osteosarcoma.

Authors:  Peter M Anderson
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

2.  The cytogenetic action of ifosfamide, mesna, and their combination on peripheral rabbit lymphocytes: an in vivo/in vitro cytogenetic study.

Authors:  S Bogiatzi; O Pagonopoulou; M Simopoulou; D Kareli; A Kouskoukis; Z Koutka; P Ipsilantis; T Lialiaris
Journal:  Cytotechnology       Date:  2013-08-15       Impact factor: 2.058

3.  Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer.

Authors:  Esmee Cm Kooijmans; Arend Bökenkamp; Nic S Tjahjadi; Jesse M Tettero; Eline van Dulmen-den Broeder; Helena Jh van der Pal; Margreet A Veening
Journal:  Cochrane Database Syst Rev       Date:  2019-03-11

Review 4.  Future Directions in the Treatment of Osteosarcoma.

Authors:  Alannah Smrke; Peter M Anderson; Ashish Gulia; Spyridon Gennatas; Paul H Huang; Robin L Jones
Journal:  Cells       Date:  2021-01-15       Impact factor: 6.600

5.  Feasibility and safety of outpatient administration of ifosfamide and etoposide for pediatric patients with Ewing sarcoma in a resource-limited setting amid the COVID-19 pandemic.

Authors:  Saliha Sarfraz; Haleema Saeed
Journal:  Pediatr Blood Cancer       Date:  2022-03-02       Impact factor: 3.838

6.  223-Radium for metastatic osteosarcoma: combination therapy with other agents and external beam radiotherapy.

Authors:  Pete M Anderson; Jacob Scott; Shireen Parsai; Stacey Zahler; Sarah Worley; Sankaran Shrikanthan; Vivek Subbiah; Erin Murphy
Journal:  ESMO Open       Date:  2020-04

Review 7.  Strategies to Mitigate Chemotherapy and Radiation Toxicities That Affect Eating.

Authors:  Peter M Anderson; Stefanie M Thomas; Shauna Sartoski; Jacob G Scott; Kaitlin Sobilo; Sara Bewley; Laura K Salvador; Maritza Salazar-Abshire
Journal:  Nutrients       Date:  2021-12-08       Impact factor: 5.717
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.